0000899243-20-008551.txt : 20200316
0000899243-20-008551.hdr.sgml : 20200316
20200316215040
ACCESSION NUMBER: 0000899243-20-008551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200312
FILED AS OF DATE: 20200316
DATE AS OF CHANGE: 20200316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stueland Katherine
CENTRAL INDEX KEY: 0001689575
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36847
FILM NUMBER: 20719150
MAIL ADDRESS:
STREET 1: 458 BRANNAN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invitae Corp
CENTRAL INDEX KEY: 0001501134
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 271701898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 374-7782
MAIL ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: InVitae Corp
DATE OF NAME CHANGE: 20121105
FORMER COMPANY:
FORMER CONFORMED NAME: Locus Development Inc
DATE OF NAME CHANGE: 20100910
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-12
0
0001501134
Invitae Corp
NVTA
0001689575
Stueland Katherine
C/O INVITAE CORPORATION
1400 16TH STREET
SAN FRANCISCO
CA
94103
0
1
0
0
Chief Commercial Officer
Common Stock
2020-03-12
4
A
0
91733
0.00
A
224786
D
Common Stock
2020-03-13
4
S
0
935
11.5775
D
223851
D
Common Stock
2020-03-13
4
S
0
65
12.60
D
223786
D
Common Stock
2020-03-16
4
S
0
10684
11.79
D
213102
D
Shares issued upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3 of the remaining award vesting on each of March 12, 2021 and March 12, 2022, subject to continued service with the Issuer through the applicable vesting dates.
These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 22, 2019.
Represents weighted average sale price. Actual sale prices ranged from $11.20 to $12.00.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
Represents a weighted average sale price. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold.
Includes an aggregate of 172,173 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
/s/ Katherine Stueland
2020-03-16